Early transient asymptomatic neutropenia associated with alemtuzumab treatment in multiple sclerosis: a case report

J Neurol. 2018 Sep;265(9):2152-2153. doi: 10.1007/s00415-018-8976-7. Epub 2018 Jul 17.

Authors

Simonetta Galgani¹, Luca Prosperini², Shalom Haggiag¹, Carla Tortorella¹, Claudio Gasperini¹

Affiliations

¹ MS Centre, Department of Neurosciences, S. Camillo-Forlanini Hospital, c.ne Gianicolense 87, 00152, Rome, Italy.
² MS Centre, Department of Neurosciences, S. Camillo-Forlanini Hospital, c.ne Gianicolense 87, 00152, Rome, Italy. [email protected].

PMID: 30019085
DOI: 10.1007/s00415-018-8976-7

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Alemtuzumab / therapeutic use*
Female
Humans
Immunologic Factors / therapeutic use*
Multiple Sclerosis, Relapsing-Remitting / blood
Multiple Sclerosis, Relapsing-Remitting / therapy*
Neutropenia / etiology*

Substances

Immunologic Factors
Alemtuzumab